Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA Probes Blood Cancer Risk From Bluebird’s Gene Therapy, Weighs Regulatory Action
(Reuters) -The U.S. Food and Drug Administration is weighing the need for regulatory action on bluebird bio’s gene therapy for a rare neurological disorder, it said on Wednesday, as the agency probes additional reports of blood cancers from its use.…
English